「対象商品Ｎｅｗ」の検索結果
90件：61～65件目を表示
-
General Announcement: July 8, 2024 Senju Pharmaceutical Co., Ltd. Notice of Orphan Drug Designation for SJP-0008 as a Treatment of Central Retinal Artery Occlusion Senju Pharmaceutical Co., Ltd. (Head
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240708.pdf -
December 22, 2025 General Announcement Senju Pharmaceutical Co., Ltd. Mochida Pharmaceutical Co., Ltd. Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222_0.pdf -
NewMytear CL Vitaclear Cool | OTC Products, etc. | Products | SENJU Pharmaceutical
Category 3 OTC medicines New Mytear® CL Vitaclear Cool Relieves tired eyes after intense use Before using eye drops while wearing soft contact lenses, check the instructions on the box and package ins
https://www.senju.co.jp/english/products/mytearvc.html -
General Announcement: May 9, 2024 Senju Pharmaceutical Co., Ltd. Senju announces initiation of Phase III Clinical Trials in Japan for “SJP-0008” for the treatment of Central Retinal Artery Occlusion S
https://www.senju.co.jp/system/files/content_news/2024-05/ENG_20240509_0.pdf -
さし心地で選べるスタンダードシリーズ | NewマイティアＣＬ｜千寿製薬
ＮｅｗマイティアＣＬ-ｓ 目のかわき・疲れに第3類医薬品 商品詳細はこちら 取り扱い店舗を探す ONLINE STORE ONLINE STORE × 閉じる ＮｅｗマイティアＣＬクール-ｓ ⽬のかわき・疲れに第3類医薬品 商品詳細はこちら 取り扱い店舗を探す ONLINE STORE ONLINE STORE × 閉じる ＮｅｗマイティアＣＬクールＨｉ-ｓ ⽬のかわき・疲れに第3類医薬品 商品詳
http://www.senju.co.jp/consumer/mytearcl/standard/